Jing Li

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

Xinan Qiao, Jun Ma, Tristan Knight et al. · Blood Cancer Journal · 2021 · 39 citations · Full text

ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease

Kyungho Kim, Jing Li, Andrew Barazia et al. · Haematologica · 2016 · 28 citations · Full text

Inflammation, Thrombosis, Thrombopoiesis +15

Hydroxyurea with AKT2 inhibition decreases vaso-occlusive events in sickle cell disease mice

Andrew Barazia, Jing Li, Kyungho Kim et al. · Blood · 2015 · 21 citations · Full text

(–)Gossypol and its combination with imatinib induce apoptosis in human chronic myeloid leukemic cells

Meng Yang, Yan Li, Jing Li et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 20 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Medicine +15

SOX6 Downregulation Induces <i>γ</i>-Globin in Human <i>β</i>-Thalassemia Major Erythroid Cells

Jing Li, Lai Yongrong, Jun Luo et al. · BioMed Research International · 2017 · 19 citations · Full text